ArticleBMC nephrology2024

Role of baseline soluble tumor necrosis factor receptor 2 as a biomarker in primary podocytopathy: Implications for renal impairment and disease progression.

Srinivas Nagaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.